Below are three things to know.
1. Interpace Diagnostics provides molecular diagnostic tests and pathology services for evaluating risk of cancer.
2. Novitas assigned the molecular current procedural terminology code 81479 to the PancraGen test used for pancreatic cysts. Prior to the change, the test was included under a miscellaneous chemistry code 84999, which is used to bill for a wide range of tests.
3. The new code is expected to streamline and positively impact the way claims are submitted and remittances are received from both Medicare and commercial payers.
More articles on health IT and revenue cycle management issues:
RJD Green completes acquisition of payment software developer: 3 things to know
GeBBS Healthcare Solutions introduces coding audit software solution
athenahealth partners with Intacct for hospital financial management: 4 things to know
